Warning: Constant CONF_ASSETS_PATH already defined in /confereneceLV/conferenece_com/conferenceseries_com/Past_Reports/dynamic/call.php on line 8
Past Conference Report of /Past_Reports/biomarkers-2022-past | Conference Series

Warning: Constant CONF_ASSETS_PATH already defined in /confereneceLV/conferenece_com/conferenceseries_com/Past_Reports/dynamic/call.php on line 8
17th World Congress on Biomarkers, Cancer Therapy & Clinical Research
September 23-24, 2022 Vancouver, Canada

Upcoming Conference

Biomarkers 2022
Biomarkers 2022 Report

The success of the Biomarkers, Cancer Therapy & Clinical Research has given us the prospect to bring the gathering one more time in Vancouver, Canada during May 27-28, 2022. Biomarkers Congress meeting engrossed a vicinity of comprehensive discussions on novel subjects like Biomarkers, Functional Genomics and Cytogenetic Biomarkers, Biomarkers in Clinical Research and Development, Biomarkers for Disorders, Techniques to Maximize Biomarker Identification, Biomarkers in Nano science, Cancer Biomarkers, Functional Transcriptomics and Profiling Techniques, Biomarkers in Toxicology, Biomarkers in Microbial Infections, Biomarkers in Drug Discovery

Biomarkers 2022 extends its warm gratitude to all the previous year’s Honourable Guest and Keynote Speakers of the event:

Biomarkers 2015 | September 01-02, 2015 | Toronto, Canada

  • Trevor G Marshall, Autoimmunity Research Foundation, USA
  • Claude Prigent, Institute of Genetics and Development of Rennes, France
  • Biswendu B Goswami, FDA Center for Food Safety and Applied Nutrition, USA
  • Sergey Suchkov, I.M.Sechenov First Moscow State Medical University, Russia
  • Alain Moreau, Sainte-Justine University Hospital, Canada
  • Chee Gee See, Proteome Sciences, UK
  • Martin Weber, Austrian Institute of Technology GmbH, Austria
  • Marsha A Moses, Harvard Medical School, USA
  • Jan Voskuil, Everest Biotech Ltd., UK
  • Scott Marshall, Precision for Medicine, USA

Biomarkers 2016 | December 05-07, 2016 | Philadelphia, Pennsylvania, USA

  • Huber Colleen, Naturopathic Oncology Research Institute, USA
  • Chen Song, Harvard Medical School, USA
  • Ying Mu, Center for Devices and Radiological Health-US FDA, USA
  • Al Charest, Beth Israel Deaconess Medical Center Cancer Center, USA
  • Jianyu Rao, David Geffen School of Medicine-UCLA, USA
  • Andrea Nicolini, University of Pisa, Italy
  • Hideshi Ishii, Osaka University Graduate School of Medicine, Japan
  • Erik Andrade Jorge, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico
  • Jose Guadalupe Trujillo Ferrara, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico
  • Cheryl McAlpine, Immunocore Ltd., UK

Biomarkers 2017 | October 18-20, 2017 | Baltimore, Maryland, USA

  • Frédéric Baribaud, Johnson & Johnson, USA
  • David Dongliang Ge, Apostle Inc, USA
  • Kamala K Maddali, Cancer Genetics Inc, USA
  • Yoshiaki Omura, New York Medical College, USA
  • Diana Anderson, University of Bradford, UK
  • Srinivas Pentyala, Stony Brook Medical Center, USA
  • Jianhua Luo, University of Pittsburgh, USA
  • Michael Retsky, Harvard School of Public Health, USA
  • David I Smith, Mayo Clinic, USA
  • John Michael Sauer, University of Arizona College of Medicine, USA
  • Nikolai V Ivanov, Philip Morris International Research & Development, Switzerland
  • Lowe Leroy, Lancaster University, UK
  • George Vasmatzise, Mayo Clinic, USA
  • Sergey Suchkov, I M Sechenov First Moscow State Medical University, Russia
  • Qing Kay Li, Johns Hopkins Medical Institutions, USA

Biomarkers 2018 | October 03-04, 2018 | Los Angeles, California, USA

  • Michael Retsky, Harvard TH Chan School of Public Health, USA
  • Jianhua Luo, University of Pittsburgh School of Medicine, USA
  • Li Zhang, The University of Texas at Dallas, USA
  • Diana Anderson, University of Bradford, UK
  • Magnus S Magnusson, University of Iceland, Iceland
  • P Schulz-Knappe, Protagen AG, Germany
  • George Vasmatzis, Mayo Clinic, USA
  • Huihuang Yan, Mayo Clinic, USA
  • Yoshiaki Omura, New York Medical College, USA
  • Sushma Umrao, Danal Al Emarat Hospital, UAE
  • Bing li, University of Louisville, USA
  • Katarína Janšáková, Comenius University, Slovakia

Biomarkers management teams offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with ConferenceSeries Ltd and supported the conference in every aspect.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Biomarkers 2015, Biomarkers 2016, Biomarkers 2017, Biomarkers 2018, Biomarkers 2019. Conference Series LLC Ltd would like to announce the commencement of the “17th World Congress on Biomarkers, Cancer Therapy & Clinical Research” to be held during May 27-28, 2022Vancouver, Canada. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Biomarkers, Cancer Therapy & Clinical Research.

Let us meet again @ Biomarkers 2022

Expert Presentations


Conference: Biomarkers 2022, Conference Series Conferences
35 Ruddlesway, Windsor,Berkshire, SL4 5SF
Contact: america@conferenceseries.com
Toll free: 0044-2033180199(USA & Canada),
0044-2033180199(Australia), 0044-2033180199(Europe)
Operated by: Editors - Journal of Molecular Biomarkers & Diagnosis, Journal of Cancer Science & Therapy and Journal of Oncology Research and Treatment
The Organizers reserve the rights to make changes and adjustment to the information in this website
Copyright 2023 Conference Series - All rights reserved